Dear valued AFAR supporter:
At the American Federation for Aging Research (AFAR), we stand firmly with the field of aging biology and the scientists who drive groundbreaking research to improve healthspan and longevity. We are deeply concerned by the proposed NIH indirect cost cuts, which could severely impact the progress of critical research, including in the aging biology space.
For over four decades, AFAR has been committed to advancing aging biology by supporting early-career scientists, many of whom are now leading the field. We will continue to champion these researchers and ensure they have the resources and opportunities to grow and innovate.
Through our Amplifying Geroscience program and ongoing federal advocacy efforts, we are actively working to ensure that aging biology and geroscience continue to receive the support they need to thrive. We are committed to doing everything we can to help researchers who may be threatened by these potential funding reductions.
We believe that cutting-edge research in aging biology has the potential to transform the future of healthcare. AFAR remains dedicated to advocating for policies that protect and promote this vital work, ensuring that scientists can continue their important contributions to understanding and addressing aging.
AFAR’s grant programs have provided vital support to individual researchers, thanks to the generosity of private foundations and individuals. We remain committed to building the research pipeline and are grateful for your support.
Together, we will continue to fight for the future of aging research and the scientists who are leading the way.
Sincerely,
Stephanie Lederman, EdM
Executive Director
